Spf30 Sunscreen

Octinoxate,oxybenzone,octisalate

Yuyao Jessie Commodity Co.,ltd.
Human Otc Drug
NDC 51414-104

Spf30 Sunscreen also known as Octinoxate,oxybenzone,octisalate is a human otc drug labeled by 'Yuyao Jessie Commodity Co.,ltd.'. National Drug Code (NDC) number for Spf30 Sunscreen is 51414-104. This drug is available in dosage form of Spray. The names of the active, medicinal ingredients in Spf30 Sunscreen drug includes Octinoxate - 7.5 g/100g Octisalate - 4 g/100g Oxybenzone - 4 g/100g . The currest status of Spf30 Sunscreen drug is Active.

Drug Information:

Drug NDC:	51414-104
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Spf30 Sunscreen
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Octinoxate,oxybenzone,octisalate
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Yuyao Jessie Commodity Co.,ltd.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Spray
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	OCTINOXATE - 7.5 g/100g OCTISALATE - 4 g/100g OXYBENZONE - 4 g/100g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	OTC MONOGRAPH NOT FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	12 Sep, 2012
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	20 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number:	part352
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	Yuyao Jessie Commodity Co.,Ltd.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UNII:	4Y5P7MUD51 4X49Y0596W 95OOS7VE0Y
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
51414-104-01	5 g in 1 PACKAGE (51414-104-01)	11 Dec, 2016	N/A	No
51414-104-02	7 g in 1 PACKAGE (51414-104-02)	11 Dec, 2016	N/A	No
51414-104-03	8 g in 1 PACKAGE (51414-104-03)	11 Dec, 2016	N/A	No
51414-104-04	10 g in 1 PACKAGE (51414-104-04)	11 Dec, 2016	N/A	No
51414-104-05	12 g in 1 PACKAGE (51414-104-05)	11 Dec, 2016	N/A	No
51414-104-06	15 g in 1 PACKAGE (51414-104-06)	11 Dec, 2016	N/A	No
51414-104-07	20 g in 1 PACKAGE (51414-104-07)	11 Dec, 2016	N/A	No
51414-104-08	25 g in 1 PACKAGE (51414-104-08)	11 Dec, 2016	N/A	No
51414-104-09	30 g in 1 PACKAGE (51414-104-09)	11 Dec, 2016	N/A	No
51414-104-10	40 g in 1 PACKAGE (51414-104-10)	11 Dec, 2016	N/A	No
51414-104-11	50 g in 1 PACKAGE (51414-104-11)	11 Dec, 2016	N/A	No
51414-104-12	60 g in 1 PACKAGE (51414-104-12)	11 Dec, 2016	N/A	No
51414-104-13	70 g in 1 PACKAGE (51414-104-13)	11 Dec, 2016	N/A	No
51414-104-14	80 g in 1 PACKAGE (51414-104-14)	11 Dec, 2016	N/A	No
51414-104-15	90 g in 1 PACKAGE (51414-104-15)	11 Dec, 2016	N/A	No
51414-104-16	100 g in 1 PACKAGE (51414-104-16)	11 Dec, 2016	N/A	No
51414-104-17	120 g in 1 PACKAGE (51414-104-17)	11 Dec, 2016	N/A	No
51414-104-18	130 g in 1 PACKAGE (51414-104-18)	11 Dec, 2016	N/A	No
51414-104-19	150 g in 1 PACKAGE (51414-104-19)	11 Dec, 2016	N/A	No
51414-104-20	160 g in 1 PACKAGE (51414-104-20)	11 Dec, 2016	N/A	No
51414-104-21	180 g in 1 PACKAGE (51414-104-21)	11 Dec, 2016	N/A	No
51414-104-22	200 g in 1 PACKAGE (51414-104-22)	11 Dec, 2016	N/A	No
51414-104-23	220 g in 1 PACKAGE (51414-104-23)	12 Dec, 2016	N/A	No
51414-104-24	250 g in 1 PACKAGE (51414-104-24)	11 Dec, 2016	N/A	No
51414-104-25	300 g in 1 PACKAGE (51414-104-25)	11 Dec, 2016	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Spf30 Sunscreen

Octinoxate,oxybenzone,octisalate

Spray
Yuyao Jessie Commodity Co.,Ltd.
NDC: 51414-104

Purpose:

Purpose sunscreen

Product Elements:

Spf30 sunscreen octinoxate,oxybenzone,octisalate tricaprylin carbomer 934 titanium dioxide glycerol formal c12-20 alkyl benzoate triethanolamine sulfate water propylene glycol octyldodecanol dmdm hydantoin octinoxate octinoxate oxybenzone oxybenzone octisalate octisalate

Indications and Usage:

Use hellps prevent sunburn. if used as directed with other sun protection measures(see dirctions),decreases the rish of skin cancer and early skin aging carsed by the sun

Warnings:

Warnings for external use only. do not us on damaged or broken skin. when using this product keep out of eyes,rinse with water to remove. stop use and ask a doctor,if rash occurs. keep out of reach of children if product is swallowed,get medical help or contact a poison control center right away.

Dosage and Administration:

Directions apply liverally 15 minutes before sun exposure. reapply afgter 40 minutes of swimming or sweating. immediately afger towel drying at least eaery 2 hours. sun portection measure,spending time in the sun increases your risk of skin cancer and early skin aging.to decrease this risk,regularly use a suncream with a broad spectrun spf of 15 higher and other sun protection measures induding : limit time in the sun especially from10 am -2pm wear long -sleeve shirts ,pants,hats,and sunglasses children under 6 months ,ask a doctor. for best results ,apply 15-30 minutes before sun exposure ,hold bottle 4-6 inches away from body and apply liberally,spraying slowly and evenly until product is visible on skin.can be applied diredtly to wet skin.reapply after swimming ,excessive perspiration,towel drying or extended sun exposure.do not apply in windy conditions.do not spray into face.spray into hand and apply to the face.use in well ventilated areas.

Package Label Principal Display Panel:

Lebel 1

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.